Sandbox:lipid: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 152: | Line 152: | ||
|May be considered depending on clinical | |May be considered depending on clinical | ||
history | history | ||
|} | |||
{| class="wikitable" | |||
! colspan="3" |Vascular Access | |||
|- | |||
!Kidney Function Status | |||
!Recommended Approach | |||
!Key Parameters | |||
|- | |||
|Normal renal function (GFR >60) or | |||
ESRD not expected to recover | |||
| | |||
* TAVR CTA | |||
|Aorta, great vessel, and abdominal aorta | |||
Dissection; atheroma; stenosis; calcification | |||
Iliac/subclavian/femoral luminal dimensions, calcification, and tortuosity | |||
|- | |||
|Borderline renal | |||
function | |||
| | |||
* Contrast MRA | |||
* Direct femoral angiography (low contrast) | |||
|Institutional dependent protocols | |||
Luminal dimensions and tortuosity of peripheral vasculature | |||
|- | |||
|Acute kidney injury or | |||
ESRD with expected | |||
recovery | |||
| | |||
* Noncontrast CT of chest, abdomen, and pelvis | |||
* Noncontrast MRA | |||
* Can consider TEE if balancing risk/benefits | |||
|Degree of calcification and tortuosity of peripheral vasculature | |||
|} | |} |
Revision as of 21:20, 12 January 2017
TAVR Imaging Evaluation | |||||||||||||||||||||||||||||||||||||||||||||||||||
TAVR CT | ECHO | ||||||||||||||||||||||||||||||||||||||||||||||||||
Non-gated Angigram of Chest, Abdomen and Pelvic arteries for vascular access selection | ECG gated CT of annulus and Aortic root for valve sizing selection | Left ventricles and other findings | Confirm severe Aortic Stenosis | ||||||||||||||||||||||||||||||||||||||||||||||||
Transfemoral Approach | Annular sizing | Aortic Root sizing | Additional Procedural Planning | ||||||||||||||||||||||||||||||||||||||||||||||||
Subclavian Approach | Major/Minor Dimension | Coronary Ostia height | Fluoroscopy Angulation | LVEF and LV dimension | High gradient AS | ||||||||||||||||||||||||||||||||||||||||||||||
Apical Approach | Area | Aortic Sinus to Commissure dimension | Bypass Grafts | Estimated Pulmonary pressure | Low gradient AS | ||||||||||||||||||||||||||||||||||||||||||||||
Other Approaches | Circumferences | Sinotubular Junction | RV to Chest wall position | Other valvular abnormalities | Reduced EF | ||||||||||||||||||||||||||||||||||||||||||||||
Carotid | Ascending Aorta dimension | Preserved EF | |||||||||||||||||||||||||||||||||||||||||||||||||
Direct Aortic | Aortic Calcification | ||||||||||||||||||||||||||||||||||||||||||||||||||
Transvenous | |||||||||||||||||||||||||||||||||||||||||||||||||||
TAVR Imaging Checklist | ||
---|---|---|
Region of Interest | Recommended Approach and Key
Measures |
Additional Comments |
Preprocedure | ||
Aortic valve morphology | TTE:
|
useful for subaortic membranes
nondiagnostic
contraindicated |
Aortic valve function | TTE:
|
Additional parameters
for LFLG AS-Reduced EF
diagnosis in question |
LV Geometry and other
cardiac findings |
TTE:
|
DSE, thallium
scar, identification of cardiomyopathies |
Annular sizing |
thorax with multiphasic acquisition
of the R-R window |
|
Aortic root measurements |
multiphasic acquisition.
|
sinus to sinus)
widest dimension, at level of PA)
|
Coronary disease and
thoracic anatomy |
|
|
Noncardiac imaging |
|
May be considered depending on clinical
history |
Vascular Access | ||
---|---|---|
Kidney Function Status | Recommended Approach | Key Parameters |
Normal renal function (GFR >60) or
ESRD not expected to recover |
|
Aorta, great vessel, and abdominal aorta
Dissection; atheroma; stenosis; calcification Iliac/subclavian/femoral luminal dimensions, calcification, and tortuosity |
Borderline renal
function |
|
Institutional dependent protocols
?Luminal dimensions and tortuosity of peripheral vasculature |
Acute kidney injury or
ESRD with expected recovery |
|
Degree of calcification and tortuosity of peripheral vasculature |